Moreover, GAS5 was shown to inhibit pancreatic cancer cell proliferation by inhibiting the transcriptional activity of glucocorticoid receptor (GR) in CD133+ population which is often attributed to tumor metastasis and recurrence (25). Here, GAS5 is linked to neoplasm.